Article
CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness.
Leukemia - 1 Oct 2021
Lewis Richard, Maurer H Carlo, Singh Nikita, Gonzalez-Menendez Irene, Wirth Matthias, Schick Markus, Zhang Le, Isaakidis Konstandina, Scherger Anna Katharina, Schulze Veronika, Lu Junyan, Zenz Thorsten, Steiger Katja, Rad Roland, Quintanilla-Martinez Leticia, Espeli Marion, Balabanian Karl, Keller Ulrich, Habringer Stefan
Abstract excerpt
Aberrant CXCR4 activity has been implicated in lymphoma pathogenesis, disease progression, and resistance to therapies. Using a mouse model with a gain-of-function CXCR4 mutation (CXCR4C1013G) that hyperactivates CXCR4 signaling, we identified CXCR4 as a crucial activator of multiple key oncogenic pathways. CXCR4 hyperactivation resulted in an expansion of transitional B1 lymphocytes, which represent the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
